To evaluate the applicability of mAbs to the development of immunoassays for dengue virus detection, dengue group-specific anti-E D1 695/12C/2H, anti-prM D1 606/A12/B9 and a flavivirus-specific anti-E D3 424/8G were used in an in-house IgM-capture assay. Here, CD40LG is linked to dengue disease.